Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer

NEXT STORY
The global market for liquid handling systems is predicted to grow at a CAGR of 7.43% over the forecast period 2021-2031
PREV STORY
Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus annonce ses résultats financiers pour le deuxième trimestre 2018 et ses résultats d’exploitation intermédiaires

Les données cliniques de la phase 1/2 de MCLA-128 tirées de la cohorte de ...

author_avatar
NASDAQ Market News

Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

author_avatar
NASDAQ Market News

nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman

GRANADA, Spain, June 1, 2016 (GLOBE NEWSWIRE) -- nLife Therapeutics, an early-stage biopharmaceutical company ...

author_avatar
NASDAQ Market News